Artificial intelligence and radiomics can help specialists predict how patients with non–small cell lung cancer (NSCLC) will respond to chemotherapy, according to new research published in Radiology: Artificial Intelligence.
Artificial intelligence and radiomics can help specialists predict how patients with non–small cell lung cancer (NSCLC) will respond to chemotherapy, according to new research published in Radiology: Artificial Intelligence.